ULS UL Solutions Inc.

XNYS 81.56 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

ULS $81.56 —
Key stats
$81.56
52-Week Range
$63.17 – $107.54
YTD
+0.80%
IV Rank (30D)
19.99
Straddle Price
$7.12
P/C Vol Ratio
0.48
Market Cap
$16.4B
Open
$80.29
Day Range
$80.06 – $81.81
Volume
584,881
Prev Close
$81.19
Fair Value
MODEL: SHORT

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.84%
Beta vs SPY0.61
Cost of Equity (CAPM)7.90% (VRP-adj)
WACC7.97%
Volatility Risk Premium+17.0pp (IV − HV30)
Effective Tax Rate26.4%
Rev. Growth (YoY, DCF input)+4.3%
DCF Horizon12 years explicit + fade
Forward Tilt (NTM/TTM)×1.04 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.5B
Return on Equity (TTM)30.1%
Book / Price10.5%
Gross Margin (TTM)50.6%
FCF Margin (TTM)15.1%
Debt / Equity0.44
Quality Score5/6 — high quality (12y DCF)
Market-Implied Growth+11.4% (reverse-DCF on current price)
SMA 50$71.13 (Market Anchor value)
SMA 20 / Bollinger Mid$74.86
Bollinger Width / SMA2015.3% (drives anchor stability)
Net Debt$-0.3B
Market Cap$17B
Peers used for multiples: ALAB, ARM, CRWV, MDLN, MEDP, MLI, RDDT, SNX
60-Day Conviction
76%
20-Day Fair Value
≈ by Dec 9, 2026
$80.36
α -1.5% rank 14%
conviction
84%
40-Day Fair Value
≈ by Jan 7, 2027
$79.94
α -2.0% rank 14%
conviction
63%
60-Day Fair Value
≈ by Feb 5, 2027
$78.75
α -3.4% rank 14%
conviction
76%
MethodImplied PriceWeightDetail
DCF $51.10 22%
DDM (Gordon) $16.41 0%
Peer P/E $70.71 10% median 26.9× · 6 peers
Peer EV/EBITDA $76.18 10% median 18.4× · 7 peers
Peer P/B $43.36 2% median 5.1× · 7 peers
Peer P/S $54.90 7% median 3.4× · 7 peers
Market Anchor (SMA50) $71.13 33% stability 73% (BB-width)
Options Expected (B-L 30d) $81.93 16% 14 strikes · skew +1.03
As of 2026-11-10 · updated
About
Industry (SIC)
SERVICES-TESTING LABORATORIES (8734) · industry map
Exchange
XNYS
Market Cap
$16.4B
Employees
14,851
List Date
2024-04-12
CIK
0001901440
Last Earnings
Nov 3 before open · +7.0% vs ±10.6% expected
Next Earnings
~Feb 18, 2027 (estimated)
Headquarters
Northbrook, IL
Homepage
https://www.ul.com

UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'24'25'26Avg
Jan--8.58%-13.20%-2.31%
Feb---0.30%17.16%8.43%
Mar--8.82%2.43%5.62%
Apr0.46%-1.14%7.00%2.11%
May10.67%22.45%8.62%13.91%
Jun10.47%1.45%1.92%4.61%
Jul20.40%4.89%-6.64%6.22%
Aug6.07%-12.14%-18.15%-8.07%
Sep-8.87%10.68%-10.67%-2.95%
Oct5.70%10.14%12.42%9.42%
Nov4.13%16.03%8.54%*9.57%
Dec-5.57%-12.57%---9.07%
Total48.56%64.88%2.78%38.74%
* Only 3 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $75.38
SMA 50: $71.27
SMA 200: $82.79
Current: $81.56
EMA 12: $77.48
EMA 26: $74.98
MACD: 2.5009 | Signal: 0.6708
BULLISH
ADX (14): 39.66
TREND
+DI: 30.74
−DI: 8.62

Momentum Oscillators

RSI (14): 67.77
NEUTRAL
Stoch %K: 76.44
Stoch %D: 64.46
Williams %R: -13.96

Volume & Volatility

BB Upper: $81.54
BB Lower: $69.22
OVERBOUGHT
OBV: 8,331,362
Vol SMA 20: 901,660
Vol ROC: -0.05%
ATR: $3.04
True Range: $1.75
HV 20: 39.7%
HV 30: 37.2%
HV 60: 34.3%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-12T00:00:00 – 2026-11-10T00:00:00
AI Analysis
Written before ULS’s Nov 3 earnings report, so it doesn’t reflect the results.

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 6/10)

Key drivers:

  • Strong technical indicators, with multiple SMA lines aligned in an uptrend
  • Low volatility, indicating a stable market environment
  • Recent positive news headlines from the medical device testing and EV battery testing industries

Primary risks:

  • Potential for increased competition in the medical device testing industry
  • Fluctuations in demand for EV batteries could impact stock performance

Investment thesis: ULS has strong technical momentum, low volatility, and recent positive news, making it a potentially attractive investment opportunity.

Recent news sentiment impact: The overall sentiment is NEUTRAL, with one POSITIVE headline from the medical device testing industry and three NEUTRAL headlines from various sectors. This neutral sentiment does not have a significant impact on our analysis.

Technical Analysis

Trend Direction:

  • Short-term: Uptrend
  • Medium-term: Uptrend
  • Long-term: Uptrend

Support/Resistance Levels:

  • SMA 20: $75.46 (support)
  • SMA 50: $83.48 (resistance)

Momentum Signals:

  • RSI interpretation: Neutral (33.56), indicating a lack of overbought or oversold conditions
  • MACD signal: Bearish (-2.69 / Signal: 0.40), suggesting a potential pullback
  • Bollinger Bands position: Neutral, with the price near the middle band

Volume Analysis:

  • Volume SMA 20: 567950.46 (low volume)
  • On-Balance Volume (OBV): 11286262.98 (neutral)
  • Volume Rate of Change: -5.26% (declining volume)

News & Sentiment Analysis

Recent Headlines Summary:

  • Medical device testing market expected to grow
  • Schneider Electric and Wallbridge Mining achieve ECOLOGO certification
  • ProSearch shares eDiscovery insights at Legalweek 2025

Sentiment Assessment: Neutral (4/5 news headlines)

Catalyst Identification:

  • Upcoming earnings reports from the medical device testing industry

Market Narrative:

  • The recent positive news headlines from the medical device testing and EV battery testing industries have contributed to the uptrend, but the neutral sentiment does not indicate a significant catalyst.

Risk & Volatility Assessment

Risk Assessment:

  • Beta: 0.61 (low risk)
  • Alpha: 0.12
  • Correlation: 0.18
  • Stock Volatility: 0.43

Options Market Signals:

  • IV Rank: Medium (36.6%)
  • Current IV: 65.2%
  • Expected Move: $5.92 (42 DTE), 7-DTE: $3.17
  • Volume Flow: 38 calls vs 179 puts (bearish sentiment)
  • Open Interest: 452 calls vs 249 puts

Downside Protection:

  • Support levels: SMA 20 ($75.46) and Bollinger Bands middle band ($75.46)

Market Context & Positioning

Sector Performance:

  • The medical device testing industry has been performing well, contributing to ULS's uptrend.

Institutional Activity:

  • Low institutional interest (Volume Rate of Change: -5.26%)

Correlation Analysis:

  • R-squared: 0.18 (low correlation with the market)

Relative Valuation:

  • Position within trading range: Near the top end of the range

Key Levels & Action Items

Critical Price Levels:

  • Support levels: SMA 20 ($75.46) and Bollinger Bands middle band ($75.46)
  • Resistance level: SMA 50 ($83.48)

Breakout/Breakdown Levels:

  • Potential breakdown: If price falls below SMA 20 ($75.46)
  • Potential breakout: If price breaks above SMA 50 ($83.48)

Time-Sensitive Catalysts:

  • Upcoming earnings reports from the medical device testing industry

Risk Management:

  • Stop-loss levels: near SMA 20 ($75.46) and Bollinger Bands middle band ($75.46)
  • Position sizing considerations: consider scaling in as support levels are approached.

This comprehensive analysis provides an objective view of ULS's technical, fundamental, and sentiment factors. The bullish trend is supported by multiple SMA lines, low volatility, and recent positive news headlines from the medical device testing industry. However, potential risks include increased competition and fluctuations in demand for EV batteries. Investors should consider scaling in as support levels are approached and monitor upcoming earnings reports from the medical device testing industry.

Generated
News
All ULS news →
Earnings History
4 of 10 under expected move
Avg Expected Move
10.00%
Avg Actual Move
10.07%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-05-20 Pre-Market 11.29% 2.15% 0.19x Within
2024-07-31 Pre-Market 10.95% 10.11% 0.92x Within
2024-11-05 Pre-Market 12.03% 0.81% 0.07x Within
2025-05-06 Pre-Market 7.67% 12.29% 1.60x Exceeded
2025-08-05 Pre-Market 7.77% 11.51% 1.48x Exceeded
2025-11-04 Pre-Market 10.24% 10.62% 1.04x Exceeded
2026-02-19 Pre-Market 9.16% 15.99% 1.75x Exceeded
2026-05-05 Pre-Market 9.43% 16.25% 1.72x Exceeded
2026-08-04 Pre-Market 10.93% 13.96% 1.28x Exceeded
2026-11-03 Pre-Market 10.55% 7.00% 0.66x Within

Earnings calendar: this week’s reports with expected vs actual moves →

ULS Options Activity & IV Rank

ULS IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 34.4%
7-DTE IV: 45.9%
Expected Move: $7.12
7-DTE Move: $5.30
Days to Exp: 38 (2026-12-18)

Options Flow · All expiries

Call Volume: 4,985
Put Volume: 2,419
P/C Volume: 0.485
BULLISH
Call OI: 6,212
Put OI: 4,446
P/C OI: 0.716
Total OI: 10,658

ATM Options Pricing

ATM Call: $3.17
ATM Put: $3.95
Call %: 3.9%
Put %: 4.8%

Chain Summary

Chain Volume: 7,404
Chain OI: 10,658
Last Updated: 11/10/2026
Spread Scanner
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 80th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
80%
vs own history
GEX tilt
+0.59
OI-weighted, today
Vanna tilt
-0.37
δ-sensitivity to IV
Charm tilt
+0.33
δ-decay vs time
Vanna tilt -0.37: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt +0.33: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 14 ATM contracts, 7k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Nov 10 · No data
30 DTE / 10d —
— pts EXTREME
as of Nov 10 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)35.4MediumNov 10
IV Rank (30 DTE)20.0LowNov 10

Embed ULS IV rank

ULS's 30-day IV rank (90 sessions) with its 52-week rank, at-the-money IV and a 90-session trend. Updates after each close. Paste the code into any web page or blog post. Email newsletters drop iframes, so link to the page there.

Theme
Preview
Straddle Price (30 DTE)$7.12Nov 10
Beta Analysis

Risk Metrics

Beta: 0.7416
Alpha: -5.24%
Correlation: 0.2375
R-Squared: 5.6%
Stock Volatility: 42.7%
Market Volatility: 13.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own ULS
3 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Soros Fund Management Family office
George Soros, Robert Soros, Jonathan Soros
$34.0M
0.45%
#71 of 251-15.5%13F
Rockefeller Capital Management Family office
Rockefeller family
$22.9M
0.04%
#451 of 4729-29.7%13F
Point72 Hedge fund
Steve Cohen
$4.5M
0.01%
#1015 of 1945new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

ULS Institutional Ownership (13F)

Filings for 2026-06-30 · 159 already for 2026-09-30
Diluted shares outstanding: 203,750,000 (as of 2026-09-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

387 filers88,838,876 shares$8.61B value43.60% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 7,131,683 $726.43M 8.44% 3.50% 2026-06-30
2 T. Rowe Price Investment Management, Inc. 6,921,422 $705.02M 8.19% 3.40% 2026-06-30
3 Capital International Investors 6,115,196 $622.88M 7.23% 3.00% 2026-06-30
4 KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4,694,443 $478.18M 5.55% 2.30% 2026-06-30
5 Vanguard Capital Management LLC 3,504,948 $357.01M 4.15% 1.72% 2026-06-30
6 Capital Research Global Investors 3,367,530 $343.00M 3.98% 1.65% 2026-06-30
7 Vanguard Portfolio Management LLC 3,241,880 $330.22M 3.83% 1.59% 2026-06-30
8 Jupiter Topco LLC 3,042,429 $309.90M 3.60% 1.49% 2026-06-30
9 Durable Capital Partners LP 2,937,488 $299.21M 3.47% 1.44% 2026-06-30
10 State Street Corp 2,279,148 $232.15M 2.70% 1.12% 2026-06-30
11 BESSEMER GROUP INC Custodian 1,870,110 $190.49M 2.21% 0.92% 2026-06-30
12 Neuberger Berman Group LLC 1,819,860 $185.37M 2.15% 0.89% 2026-06-30
13 Norges Bank 1,486,850 $151.45M 1.76% 0.73% 2026-06-30
14 FMR LLC Custodian 1,388,891 $141.47M 1.64% 0.68% 2026-06-30
15 T. Rowe Price Associates, Inc. 1,338,282 $136.32M 1.58% 0.66% 2026-06-30
16 First Trust Advisors LP 1,301,960 $132.62M 1.54% 0.64% 2026-06-30
17 Geode Capital Management, LLC Custodian 2,013,658 $132.16M 1.53% 0.99% 2026-09-30
18 Wells Fargo & Company Custodian 1,144,170 $116.55M 1.35% 0.56% 2026-06-30
19 FEDERATED HERMES, INC. 1,093,754 $111.41M 1.29% 0.54% 2026-06-30
20 Allspring Global Investments Holdings, LLC 1,438,974 $95.69M 1.11% 0.71% 2026-09-30
21 Morgan Stanley Custodian 880,673 $89.71M 1.04% 0.43% 2026-06-30
22 Thrivent Financial for Lutherans 1,316,704 $86.40M 1.00% 0.65% 2026-09-30
23 Driehaus Capital Management LLC 823,352 $83.87M 0.97% 0.40% 2026-06-30
24 SCOPUS ASSET MANAGEMENT, L.P. 768,379 $78.27M 0.91% 0.38% 2026-06-30
25 UBS Group AG Custodian 752,303 $76.63M 0.89% 0.37% 2026-06-30
11 filers$52.16M notional
# Filer Notional Value % of Total Period
1 Oribel Capital Management, LP $21.55M 41.32% 2026-06-30
2 Susquehanna International Group, LLP Custodian $8.56M 16.40% 2026-06-30
3 GROUP ONE TRADING LLC Custodian $5.81M 11.13% 2026-06-30
4 IMC-Chicago, LLC Custodian $4.23M 8.11% 2026-09-30
5 Citadel Advisors LLC Custodian $3.55M 6.82% 2026-06-30
6 Walleye Trading LLC $2.89M 5.55% 2026-06-30
7 BOOTHBAY FUND MANAGEMENT, LLC $2.22M 4.26% 2026-06-30
8 Simplex Trading, LLC Custodian $1.10M 2.11% 2026-09-30
9 D. E. Shaw & Co., Inc. Custodian $1.02M 1.95% 2026-06-30
10 Jane Street Group, LLC Custodian $967.67K 1.86% 2026-06-30
11 Walleye Capital LLC $254.65K 0.49% 2026-06-30
10 filers$46.36M notional
# Filer Notional Value % of Total Period
1 SCOPUS ASSET MANAGEMENT, L.P. $20.37M 43.94% 2026-06-30
2 Citadel Advisors LLC Custodian $12.58M 27.13% 2026-06-30
3 Susquehanna International Group, LLP Custodian $7.05M 15.20% 2026-06-30
4 Jane Street Group, LLC Custodian $3.98M 8.59% 2026-06-30
5 IMC-Chicago, LLC Custodian $741.51K 1.60% 2026-09-30
6 GROUP ONE TRADING LLC Custodian $570.42K 1.23% 2026-06-30
7 Citigroup Inc. Custodian $538.08K 1.16% 2026-09-30
8 Walleye Trading LLC $417.63K 0.90% 2026-06-30
9 Walleye Capital LLC $71.30K 0.15% 2026-06-30
10 Simplex Trading, LLC Custodian $39.37K 0.08% 2026-09-30

ULS Insider Trading (Form 4)

Latest: 2026-11-04
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-11-04 Jennifer F. Scanlon President and CEO Sell (S) −12,500 $75.03 -$937.9K EDGAR
2026-10-09 Jennifer F. Scanlon President and CEO Sell (S) −12,500 $70.08 -$876.0K EDGAR
2026-10-07 Vikram Kini Director Grant (A) +278 RSU — EDGAR
2026-10-07 Michael H Thaman Director Grant (A) +444 RSU — EDGAR
2026-09-14 Friedrich Hecker Director Grant (A) +4 RSU — EDGAR
2026-09-14 Michael H Thaman Director Grant (A) +4 RSU — EDGAR
2026-09-14 Linda S Chapin EVP & CHRO Grant (A) +9 RSU — EDGAR
2026-09-14 Ryan D Robinson Executive VP & CFO Grant (A) +39 RSU — EDGAR
2026-09-14 James P Dollive Director Grant (A) +4 RSU — EDGAR
2026-09-14 Charles W Hooper Director Grant (A) +19 RSU — EDGAR
2026-09-14 Vikram Kini Director Grant (A) +4 RSU — EDGAR
2026-09-14 Alex Dadakis See Remarks Grant (A) +40 RSU — EDGAR
2026-09-14 Kevin Kennedy Director Grant (A) +19 RSU — EDGAR
2026-09-14 Gitte Schjotz See Remarks Grant (A) +25 RSU — EDGAR
2026-09-14 Marla C Gottschalk Director Grant (A) +19 RSU — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

ULS Insider Holdings

25 insiders · @ $81.56
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 ULSE Inc. 10%+ Owner 1,875,000 $152.93M -$3.34B 5 2025-12-23
2 Jennifer F. Scanlon President and CEO 206,209 $16.82M -$6.09M 27 2026-11-04
3 Ryan D Robinson Executive VP & CFO 166,514 $13.58M $2.00M 20 2026-09-14
4 Frank J Coyne Director 112,069 $9.14M $3.00M 7 2025-05-06
5 James P Dollive Director 79,160 $6.46M $2.00M 15 2026-09-14
6 Marla C Gottschalk Director 71,428 $5.83M $2.00M 15 2026-09-14
7 Gitte Schjotz See Remarks 59,341 $4.84M -$4.58M 26 2026-09-14
8 Weifang Zhou See Remarks 46,361 $3.78M $750.0K 11 2025-06-11
9 Kevin Kennedy Director 35,714 $2.91M $1000.0K 15 2026-09-14
10 John A Genovesi See Remarks 31,013 $2.53M $513.4K 17 2026-09-14
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

ULS Board & Officers

As of SEC filings through Nov 4, 2026

Directors 12

Officers 11

  • Jennifer F. Scanlon · President and CEO · since Apr 12, 2024
  • Lynn H Hancock · Executive Vice President & Chief Transformation Officer · since Apr 12, 2024
  • Alex Dadakis · Executive Vice President and President, Testing, Inspection and Certification · listed since Sep 2025
  • Gitte Schjotz · Executive Vice President, Chief Business Operations and Innovation Officer · listed since Sep 2025
  • John A Genovesi · Executive Vice President & President, Risk & Compliance Software · listed since May 2026
  • Ryan D Robinson · Executive VP & CFO · since Apr 12, 2024
  • Alberto Uggetti · EVP & Cco · since Apr 12, 2024
  • Linda S Chapin · EVP & CHRO · since Apr 12, 2024
  • Scott D'Angelo · EVP, CLO & Corporate Secy · since Apr 21, 2025
  • Kelly Manthey · EVP, AI and Digital Trust · since Oct 1, 2026
  • Karen K Pepping · Senior VP & CAO · since Apr 12, 2024

10% owners 1

Changes in the last 10 years (37)
Oct 1, 2026Kelly Manthey became EVP, AI and Digital Trust
May 5, 2026John A Genovesi listed as Executive Vice President & President, Risk & Compliance Software (previously Executive Vice President & President, Software and Advisory) in SEC filings
Sep 10, 2025Gitte Schjotz listed as Executive Vice President, Chief Business Operations and Innovation Officer (previously Executive Vice President and Chief Operations and Sustainability Officer) in SEC filings
Sep 10, 2025Alex Dadakis listed as Executive Vice President and President, Testing, Inspection and Certification (previously Executive Vice President, Chief Business Operations and Innovation Officer) in SEC filings
Aug 14, 2025The company announced the departure of Weifang Zhou as Executive Vice President & President, Testing, Inspection and Certification in an SEC filing
May 20, 2025Vikram Kini became a director
Apr 21, 2025Scott D'Angelo became EVP, CLO & Corporate Secy
Apr 3, 2025Gitte Schjotz listed as Executive Vice President and Chief Operations and Sustainability Officer (previously Executive Vice President & Chief Science and Operations Officer) in SEC filings
Mar 5, 2025Alex Dadakis listed as Executive Vice President, Chief Business Operations and Innovation Officer (previously EVP, CBO & Innovation Officer) in SEC filings
Feb 11, 2025The company announced the departure of Lisa Marie Lambert from the board in an SEC filing
Feb 11, 2025The company announced the departure of Frank J Coyne from the board in an SEC filing
Jan 27, 2025Alex Dadakis became EVP, CBO & Innovation Officer
Aug 17, 2024The company announced the departure of Jacqueline K McLaughlin as EVP & CLO in an SEC filing
Apr 12, 2024Weifang Zhou became Executive Vice President & President, Testing, Inspection and Certification
Apr 12, 2024ULSE Inc. became a 10% owner
Apr 12, 2024Sally Susman became a director
Apr 12, 2024Ryan D Robinson became Executive VP & CFO
Apr 12, 2024Michael H Thaman became a director
Apr 12, 2024Marla C Gottschalk became a director
Apr 12, 2024Lynn H Hancock became Executive Vice President & Chief Transformation Officer
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

ULS Proposed Insider Sales (Form 144)

Latest: 2026-10-08
Last 30d: 0 filings  ·  Last 90d: 1 filing · $2.3M notice value · 1 unique filer · 100% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: JENNIFER SCANLON (1, $2.3M)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-10-08 JENNIFER SCANLON Director, Officer 35,000 $2.35M 2026-10-08 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-07-01 JENNIFER SCANLON Director, Officer 37,500 $3.82M 2026-07-01 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-06-09 PEPPING KAREN K Officer 725 $70.9K 2026-06-09 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2026-06-03 Schjotz Gitte Officer 9,865 $956.7K 2026-06-03 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2026-06-02 Schjotz Gitte Officer 12,015 $1.20M 2026-06-02 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2026-05-28 Uggetti Alberto Officer 2,345 $234.2K 2026-05-28 Fidelity Brokerage Services LLC 10b5-1 EDGAR
2026-05-21 Hecker Friedrich Director 4,000 $408.2K 2026-05-21 Freedom24 — EDGAR
2026-05-11 Alberto Uggetti Officer 6,100 $612.7K 2026-05-11 Freedom24 — EDGAR
2026-05-08 Gitte Schjotz Officer 8,000 $795.3K 2026-05-07 Freedom24 — EDGAR
2026-04-01 JENNIFER F SCANLON Director, Officer 37,500 $3.21M 2026-04-01 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-03
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-11-03 Earnings results · Regulation FD disclosure EDGAR
2026-10-01 Regulation FD disclosure EDGAR
2026-08-04 Earnings results · Regulation FD disclosure EDGAR
2026-06-03 Director or officer change EDGAR
2026-05-22 Shareholder vote results EDGAR
2026-05-05 Earnings results · Regulation FD disclosure EDGAR
2026-04-13 Regulation FD disclosure · Other events EDGAR
2026-02-19 Earnings results EDGAR
2025-12-05 Other events EDGAR
2025-11-04 Earnings results · Restructuring costs EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-19 0001901440-26-000005 EDGAR
2025-02-20 0001901440-25-000012 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-11-03 0001901440-26-000031 EDGAR
2026-08-04 0001901440-26-000023 EDGAR
2026-05-05 0001901440-26-000012 EDGAR
2025-11-04 0001901440-25-000047 EDGAR
2025-08-05 0001901440-25-000030 EDGAR
2025-05-06 0001901440-25-000019 EDGAR
2024-11-05 0001901440-24-000023 EDGAR
2024-07-31 0001901440-24-000012 EDGAR
2024-05-20 0001628280-24-024348 EDGAR
ETF Holders
136 ETFs hold ULS
25 shown · $1.01B total exposure · 0.08% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 IJH iShares Core S&P Mid-Cap ETF iShares (BlackRock) 0.18% $222.4M $125.2B 2026-11-06
2 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.01% $162.8M — 2026-09-30
3 VB Vanguard Morningstar Small-Cap ETF Vanguard 0.06% $115.5M — 2026-09-30
4 VBK Vanguard Morningstar Small-Cap Growth ETF Vanguard 0.15% $64.3M — 2026-09-30
5 SDVY First Trust SMID Cap Rising Dividend Achievers ETF First Trust 0.58% $63.9M $11.1B 2026-11-06
6 VXF Vanguard Extended Market ETF Vanguard 0.06% $57.8M — 2026-09-30
7 XMHQ Invesco S&P MidCap Quality ETF Invesco 0.82% $46.6M — 2026-11-08
8 MDY State Street® SPDR® S&P MIDCAP 400® ETF Trust SPDR (State Street) 0.18% $46.5M $25.5B 2026-11-06
9 IJK iShares S&P Mid-Cap 400 Growth ETF iShares (BlackRock) 0.37% $37.5M $10.5B 2026-11-06
10 SPMD State Street® SPDR® Portfolio S&P 400™ Mid Cap ETF SPDR (State Street) 0.18% $33.7M $18.4B 2026-11-06
11 SCHA Schwab U.S. Small-Cap ETF Nport 0.12% $27.6M — 2026-08-31
12 IWR iShares Russell Mid-Cap ETF iShares (BlackRock) 0.05% $26.0M $58.7B 2026-11-06
13 RSMC Rockefeller U.S. Small-Mid Cap ETF Nport 1.88% $14.4M — 2026-07-31
14 IWP iShares Russell Mid-Cap Growth ETF iShares (BlackRock) 0.07% $11.8M $17.4B 2026-11-06
15 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.01% $11.2M — 2026-11-06
16 MDYG State Street® SPDR® S&P 400™ Mid Cap Growth ETF SPDR (State Street) 0.37% $10.2M $2.7B 2026-11-06
17 IWD iShares Russell 1000 Value ETF iShares (BlackRock) 0.01% $8.7M $84.7B 2026-11-06
18 IVOO Vanguard S&P Mid-Cap 400 ETF Vanguard 0.15% $8.6M — 2026-09-30
19 ITOT iShares Core S&P Total U.S. Stock Market ETF iShares (BlackRock) 0.01% $8.0M $95.6B 2026-11-06
20 IWF iShares Russell 1000 Growth ETF iShares (BlackRock) 0.01% $7.9M $118.1B 2026-11-06
21 LRGF iShares U.S. Equity Factor ETF iShares (BlackRock) 0.18% $6.3M $3.7B 2026-11-06
22 VIS Vanguard Industrials ETF Vanguard 0.07% $6.2M — 2026-09-30
23 SMLF iShares U.S. Small-Cap Equity Factor ETF iShares (BlackRock) 0.14% $5.8M $4.3B 2026-11-06
24 IWS iShares Russell Mid-Cap Value ETF iShares (BlackRock) 0.04% $5.7M $14.7B 2026-11-06
25 IUSG iShares Core S&P U.S. Growth ETF iShares (BlackRock) 0.02% $5.4M $31.5B 2026-11-06
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
32.37
TTM Diluted EPS
$2.52
TTM Revenue
$3.19B
TTM Net Income
$513.00M
TTM Op. Cash Flow
$738.00M
Quarterly figures (10 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q3 '262026-09-30$823.00M$108.00M$0.53$215.00M
Q2 '262026-06-30$816.00M$246.00M$1.21$160.00M
Q1 '262026-03-31$758.00M$92.00M$0.45$219.00M
Q4 '252025-12-31$789.00M$67.00M$0.33$144.00M
Q3 '252025-09-30$783.00M$100.00M$0.49$155.00M
Q2 '252025-06-30$776.00M$91.00M$0.45$147.00M
Q1 '252025-03-31$705.00M$67.00M$0.33$154.00M
Q4 '242024-12-31$739.00M$81.00M$0.40$130.00M
Q3 '242024-09-30$731.00M$88.00M$0.44$150.00M
Q2 '242024-06-30$730.00M$101.00M$0.50$103.00M
Q3 2026 • period ending 2026-09-30 • filed 2026-11-03
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
32.37
P/B
10.25
P/S
5.28
EV/EBITDA
20.92
EV/Sales
5.23
ROE
31.2%
ROA
16.2%
Div Yield
0.70%
FCF Yield
4.08%
Debt/Equity
0.19
Current Ratio
—
Market Cap
$16.60B
as of 2026-11-10

ULS vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
ARM Arm Holdings plc American Depositary Sha $199.3B — — +58.2% 27
ALAB Astera Labs, Inc. Common Stock $37.9B 86.1 +115.2% +20.4% 40
MDLN Medline Inc. Class A common stock $35.8B 0.0 — +0.7% 5
CRWV CoreWeave, Inc. Class A Common Stock $27.0B — +115.3% −38.6% 79
RDDT Reddit, Inc. $19.5B 20.2 +62.2% −59.2% 23
MEDP Medpace Holdings, Inc. Common Stock $18.8B 36.8 +20.4% +16.4% 9
SNX TD SYNNEX Corporation $18.2B 14.2 +24.1% +51.5% 73
ULS UL Solutions Inc. $16.4B 32.4 +6.1% +0.8% 20
MLI Mueller Industries, Inc. $11.9B 17.1 +20.8% −5.8% 30
Peer median $23.2B 18.6 +43.2% +8.5% 28

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
5.47M
SI % of Float
7.23%
Days to Cover
4.28
Short Vol Ratio
66.7%
Free Float
75.62M
Float %
96.8%
Short interest 2026-10-15 • Short volume 2026-11-10 • Float 2026-10-07